Fusion Pharmaceuticals Shareholders Approve AstraZeneca Deal-March 2024-www.financetom.com

Fusion Pharmaceuticals Shareholders Approve AstraZeneca Deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Fusion Pharmaceuticals Shareholders Approve AstraZeneca Deal

May 29, 2024 2:22 PM

05:12 PM EDT, 05/29/2024 (MT Newswires) -- Fusion Pharmaceuticals ( FUSN ) said late Wednesday it received shareholder approval for the company's proposed acquisition by AstraZeneca ( AZN ) .

The company said the deal is expected to close in Q2, subject to court approval and other conditions.

Previous page： Sony, Apollo Said To Be In Talks To Access Struggling Paramount's Financials To Pave Way For Potential $26B Acquisition Next page： The rise and fall of Bill Hwang's Archegos Capital Management

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sony, Apollo Said To Be In Talks To Access Struggling Paramount's Financials To Pave Way For Potential $26B Acquisition

May 9, 2024

Sony Group Corp ( SONY ) and Apollo Global Management Inc ( APO ) are reportedly in discussions with Paramount Global ( PARAA ) to gain access to the latter’s financial records, a move that could potentially lead to a $26 billion acquisition. What Happened: Paramount Global ( PARAA ) is currently in talks to share its financial information with...

The rise and fall of Bill Hwang's Archegos Capital Management

May 9, 2024

NEW YORK (Reuters) - Sung Kook Bill Hwang, founder of the $36 billion private investment firm Archegos Capital Management which collapsed spectacularly in 2021, arrived in court on Wednesday for the start of his criminal trial. Here is a timeline of the fund's blow up - one of the biggest in years - which left global banks with $10 billion...

Howard Hughes' Q1 Loss Widens, Revenue Falls

May 9, 2024

04:54 AM EDT, 05/09/2024 (MT Newswires) -- Howard Hughes (HHH) reported a Q1 loss late Wednesday of $1.06 per diluted share, widening from a loss of $0.46 a year earlier. One analyst polled by Capital IQ expected a loss of $0.70. Revenue for the quarter ended March 31 was $171.1 million, compared with $196.3 million a year earlier. One analyst...

Sabra Health Care REIT Q1 Adjusted Funds From Operations, Revenue Rise

May 9, 2024

05:03 AM EDT, 05/09/2024 (MT Newswires) -- Sabra Health Care REIT ( SBRA ) reported late Wednesday Q1 adjusted funds from operations of $0.35 per diluted share, up from $0.34 a year earlier. Analysts polled by Capital IQ expected $0.34. Revenue for the quarter ended March 31 was $166.7 million, up from $161.3 million a year earlier. Analysts polled by...